Vanguard Asset Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.59M Buy
120,728
+42,124
+54% +$1.78M ﹤0.01% 1091
2026
Q2
$3.7M Buy
78,604
+24,586
+46% +$608K ﹤0.01% 1223
2026
Q1
$1.02M Buy
+54,018
New +$917K ﹤0.01% 1780

Other funds holding DFTX

Vanguard Asset Management's DFTX Position: Q3 2026 in Review

Vanguard Asset Management increased its Definium Therapeutics (DFTX) stake by 54% in Q3 2026, buying an estimated $1.78M and bringing the position to 120,728 shares worth $4.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Vanguard Asset Management first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Vanguard Asset Management held 120,728 shares of Definium Therapeutics worth $4.59M as of Q3 2026.
  • Vanguard Asset Management bought 42,124 Definium Therapeutics shares in Q3 2026, an estimated $1.78M.
  • Definium Therapeutics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1091 holding.
  • Vanguard Asset Management first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.